Top 50 Biotechnology VC (Venture Capital) Funds in Austria in October 2023

Portfolio highlights

• Prewave — Supplier monitoring for purchasing, supply chain management and sustainability managers.
• subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
• ReCatalyst — REvolutionizing the way we make fuel cell CATALYSTs

Portfolio highlights

• Circly — Determining tomorrow's needs through sales figures is one of Circly's core competencies, but we go one step further:Circly develops interactive AI construction modules for retailers. Thanks to our modular concept, our users can choose the influencing factors themselves and weight them differently, so that the AI can be adapted to thecompany at any time.With Circly, the supply chain and warehouse utilization can be brought to the next level. We are about to pilot the system and are looking for retailers who are interested in case studies.Description: Machine Learning based Prediction System for the retail sector to forecast the demand in order to avoid food waste, out of stocks and overstock. Other benefits include insights into customer segments and groups, product trends, the possibility of dynamic pricing and marketing!
• Sarcura — Sarcura develops a machine platform for the large scale, GMP manufacturing of personalized cell therapies. Our target is to scale global manufacturing capacity for these life saving, patient specific cancer treatments, cost effective and safe for a all patients. We will transform existing manufacturing paradigms by using semiconductor technologyto bring bioprocess control to cellular level.
• Shopstory — boomerank is a SaaS that helps eCommerce companies grow automatically with help of a powerful AI and the creation of an immense data hub.

Portfolio highlights

• Brusli — Brusli provides solutions and strategies for the reduction of food waste.
• revitalyze — revitalyze is an award-winning greentech platform that enables a circular construction industry through a unique approach to the reuse of building elements.
• Lightning Company — The Lightning Company is the first EU-based bitcoin and lightning payment gateway. We want to make bitcoin payments as easy and attractive as possible, ensuring that customers have no additional costs, whilst merchants receive attractive processing fees.

Portfolio highlights

• AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
• mbiomics — mbiomics is a biotechnology company.
• Look Up Space — Lookup space is the next global leader for space safety, security and sustainability

Portfolio highlights

• AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
• Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.
• Calyxha Biotechnologies GmbH — A new perspective on inflammation

Portfolio highlights

• Valutico — Valutico is the world‘s leading provider of web-based company valuation tools.Started in 2014 by a team of enthusiastic Corporate Finance professionals and web developers, the concept was born out of frustration with the status-quo in Corporate Finance practice: That professional company valuations used to be the domain of only the mostsophisticated of investors.At Valutico, it has been their mission from the outset to offer cutting-edge valuation tools to a much wider audience. Today they empower everybody to perform company valuations that meet and exceed the standards of even the leading investment banks and advisory firms.The company today is headquartered in Vienna/Austria and has an additional office in Frankfurt/Germany.
• ToolSense — Connecting the way OEMs do business.ToolSense enables OEMs to improve customer service, generate insights for R&D and increase customer loyalty - through digitizing their products with the 'ToolSense NOW' IIoT platform and 'ToolSense IOT' Hardware.ToolSense is the winner of Austrian Foreign Trade Award "Born GlobalChampion 2018", ORF Futurezone Award "Best IoT Startup 2017", part of Deutsche Telekom's "hub:raum NB-IoT Warp Program", part of SAP's "Startup Focus Program" and part of University of Applied Sciences Technikum Vienna's "Student Startup Incubator Program".
• Arkeon Biotechnologies — Arkeon turns CO2 into functional, carbon-negative ingredients for food

Portfolio highlights

• Neotiv — Enabling cognitive health
• Wingfield — Wingfield ist dein Zugang zu einem virtuellen Tenniserlebnis.
• InLine-Med — Radiologists perform safe, precise & easy interventions with the InLine-Med surgical tools and assistance devices.

Portfolio highlights

• Txture — Txture is an end-to-end cloud transformation platform for planning transformations, migration management and cloud infrastructure optimization.
• a:head bio — a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
• HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.

Portfolio highlights

• Silveray — Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
• KetoSwiss — KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases. It develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolicdysfunction (such as Alzheimer's disease). KetoSwiss is headquartered at the Technologie Park Basel, in Basel Switzerland, where it is part of a dynamic scientific and entrepreneurial community composed of world-leading academic research laboratories, flourishing life sciences spin-offs and s world-leading biotech-startup-ecosystem.
• WiseWorks — AI-Powered Communications Intelligence for Financial Institutions

Portfolio highlights

• sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
• Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of
• Refined Laser Systems — Refined Laser Systems is a dynamic biophotonics company.It specialises in creating innovative laser systems for SRS-microscopy and quantum technology.

Portfolio highlights

• FERNRIDE — Fernride enables automated, sustainable logistics by combining the skills of remote drivers with autonomous technologies.
• Valutico — Valutico is the world‘s leading provider of web-based company valuation tools.Started in 2014 by a team of enthusiastic Corporate Finance professionals and web developers, the concept was born out of frustration with the status-quo in Corporate Finance practice: That professional company valuations used to be the domain of only the mostsophisticated of investors.At Valutico, it has been their mission from the outset to offer cutting-edge valuation tools to a much wider audience. Today they empower everybody to perform company valuations that meet and exceed the standards of even the leading investment banks and advisory firms.The company today is headquartered in Vienna/Austria and has an additional office in Frankfurt/Germany.
• Ohana — Ohana helps you to protect your child in the digital world. Limit screentime, get insights & guidance, block apps & websites and filter inappropriate content.

Portfolio highlights

• basys.ai — Basys.ai automates the process of prior authorization and utilization management to improve costs and timeliness for health plans/payers using an AI-based platform. The proprietary platform automates the process of encoding/digitizing the payer policies using machine learning, thus reducing the piloting timeline by up to 9 months.
• Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
• ALFIE — AI software platform that provides consistent and automated measurements from radiographic images used to assess spinal disorders.

Portfolio highlights

• SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
• Cosmica Biosciences — Cosmica.bio - Rewiring molecular resilience for longevity & space exploration
• Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.

Portfolio highlights

• Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
• Avantium — Avantium is a leading technology company specialized in advanced high-throughput R&D for applications in the energy, chemicals and pharmaceutical industries. The company's headquarters and laboratories are located in Amsterdam, in the Netherlands.Avantium's proprietary high-throughput technology enables a faster and morecost-effective development of new and improved products and production processes. Using its unique rational approach towards the design of experiments and data analysis, Avantium is capable of accomplishing innovations with superior success rate. Avantium has demonstrated the validity and commercial viability of its technology by successfully providing research services and tools to more than 70 companies worldwide, including many industry leaders. The company's mission is to increase the success rate and economics of product and process development.Building on its expertise and track record in the energy, chemicals and pharmaceutical industries, Avantium focuses on developing products in two fields:new biofuels and bio-based chemicals, and new crystal forms of marketed drugs under patent.Avantium's strategy is to progress its development programs and exploit the commercial value of its expanding patent portfolio by securing value-adding partnerships during the coming years. Avantium seeks continuous expansion of its profitable services and tools business.Avantium has assembled a team of highly educated professionals who are experts in catalysis, crystallography, organic chemistry, engineering of robotic systems, process engineering, statistics, cheminformatics and software development. Its teams collaborate closely with partner R&D organizations.
• F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.

Portfolio highlights

• Angle Health — Digital-First Health Plans For The Modern Employee
• KURUKURU — Bring your comics and visual stories to life in clicks on KURUKURU.
• Leadoptik — Leadoptik is a California-based company is currently operating in stealth mode.

Portfolio highlights

• Aerones — Robotic wind turbine service company offering maintenance, inspection and repairs worldwide. Reduce downtime and improve the efficiency of your wind park
• Virtonomy GmbH — Virtonomy is shortening time-to-market of medical products by conducting data driven studies on virtual patients.
• Celeris Therapeutics — Celeris Therapeutics is a deep learning company that uses innovative, computer-based methods to degrade undruggable targets. The platform Celeris One exploits the potential of degrader technologies with accurate predictions of biomolecular interactions and the expansion of chemical space.Celeris One uses methods such as Graph RepresentationLearning, Active Learning, Data Augmentation, and Generative Models to expand the chemical space and leverage sparse and heterogeneous data. This leads to the design of Heterobifunctional and Glue Degraders, as well as Small Molecules.

Portfolio highlights

• IdoSell — IdoSell Shop is a complex service available in SaaS model directed to professional online shops and wholesale stores.
• Gett — Gett is a technology platform focused on corporate Ground Transportation Management (GTM), where spend is estimated to exceed $100 billion globally. https://gett.com/why We are the GTM category leader, serving over a quarter of the Fortune 500 companies.Gett’s cloud-based software organizes thousands of transportation providers(corporate fleet, ride-hailing, taxi, and limos) into one single platform. The technology helps save businesses time and money by managing all their ground transportation spend, and optimizes the entire employee experience from booking and riding to invoicing and analytics.We are building the first ground transportation grid available to customers worldwide, similar to telephony and internet grids, with aspirations to become the standard in corporate ground transportation, just as Zoom became the standard in corporate communication.Founded in 2010 and headquartered in London, Gett has raised more than $750M in funding to date, including more than $300M from the Volkswagen Group. They employ over 800 employees globally.
• ANSWEAR.com —

Portfolio highlights

• Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
• Aer Therapeutics — Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs.
• Convergent Therapeutics — Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company focused on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy developed by Dr. Neil Bander, Professor of Urologic Oncology at Weill Cornell Medicine andlicensed to Convergent by Cornell University. CONV 01-α, a monoclonal antibody conjugated with 225Ac, a radioactive alpha particle emitter, was specifically designed to bind to the prostate-specific membrane antigen (PSMA). A key functional feature of CONV 01-α is that, once bound to PSMA, it becomes internalized, thereby delivering its powerful radioactive payload directly into the prostate cancer cells. CONV 01-α is covered by multiple issued U.S. and foreign patents. If FDA-approved, CONV 01-α would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment.

Portfolio highlights

• AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
• SuppreMol — SuppreMol is a privately held biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases which could lead to the cure of these disorders instead of merely treating their symptoms.
• Efficient Energy — Efficient Energy GmbH is an innovative manufacturer and system supplier of environmentally friendly refrigeration technology, based in Feldkirchen near Munich, Germany. The company developed the Bluezero-technology, which uses water as a refrigerant and and thereby entirely avoids fluorinated refrigerants (HFCs). Efficient Energy helps itscustomers overcome the increasing regulatory challenges of refrigeration technology, and offers them long-term, sustainable solutions with its eChiller model range. The eChiller chilled water units are ideally suited for process cooling, machine cooling and the cooling of technical equipment and data centres and provide cooling capacities from 35 kW to 120 kW, depending on the model. With its outstanding cost efficiency and low CO2 footprint, companies benefit on many fronts. The pioneering technology has also been noticed by politics and the media, and has received multiple awards for the eChiller. These include among others the European Business Award for the Environment 2018/2019 from the European Comission and the Red Herring Europe Top 100 in 2020.

Portfolio highlights

• Mariana Oncology — Mariana Oncology is a biotechnology research industry.
• Seamless Therapeutics — Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.
• Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is

Portfolio highlights

• Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
• Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
• Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

Portfolio highlights

• Tausight — Tausight is specifically designed to help Healthcare ensure the confidentiality, integrity, and availability of ePHI.
• Candesant Biomedical — Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis. It offers a technology that is based on the principle that alkali metals in contact with water generate energy. The insight was that when the amounts of metal and water are controlled, the result is targeted delivery of energy exactly at the site of the water. Itsdevice is designed to target and inactivate the most active sweat glands.The company was founded in 2016 and is headquartered in San Francisco, California.
• Crossbow Therapeutics — Crossbow Therapeutics is a seed-stage, stealth-mode oncology startup company. The company develops antibody engineering for intracellular cancer targets.

Portfolio highlights

• Hakuma — Belebender Boost aus der Natur | Premium Zutaten | Bio Matcha-Tee | 100% vegan
• Econutri — Recycling CO2 for sustainable protein production

Portfolio highlights

• Aepsy — Finde Psychologinnen oder Psychologen, die zu dir und deinem Anliegen passen. Freite Termine und kostenlose Intros jederzeit online.
• Fermify — We are here to domesticate microorganisms and build simple and fully automated production platform to address the issue of large-scale milk protein production
• Exakt Health — Exakt Health is the physio app for sports injuries. The Exakt Health app guides users through self-diagnosis for frequent sports injuries and then creates an individualized rehabilitation plan.

Portfolio highlights

• Antaris — The Antaris Open Space platform simplifies the design, simulation, manufacturing and operation of satellites.
• Orakl Oncology — Cultivated with love by the Orakl team.
• Renaissance Fusion — Renaissance Fusion is a high-temperature superconductor and stellarator company.

Portfolio highlights

• AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.

Portfolio highlights

• Loki Foods — We're producing sustainable, plant-based foods from the Arctic. Iceland’s first plant-based cod and seafood!
• THE PACK — Nutritionally complete vegan dog food. Grain-free & developed with food scientists & animal nutritionists, try our delicious vegan dog food now.
• Swedish Temptations — Swedish Temptations, founded in 2019 by CEO Pia Qvarnström, built a brand named Bärta for producing organic, vegan and fermented food. The ingredients include Swedish split peas.

Portfolio highlights

• CleanHub — Become plastic neutral with CleanHub and prevent ocean bound plastic before it can cause damage
• Openvolt — A developer friendly API for unlocking access to smart meter data across Europe. Build more impactful apps in Energy Efficiency, ESG, EV Charging, Demand Response and a host of other use cases.
• E-mobilio — E-mobilio is a consulting and mediation platform for electromobility.

Portfolio highlights

• Seasy.com — Making Sea Life Easy
• triply — Sustainable mobility made easy. We help companies and organizations design safe and sustainable mobility solutions.
• simplify.art — simplify.art is building a safe admin and communication platform for artists and collectors. It is the first tool with a fully unlimited free basic version. The first service with data sharing between users. And the first to integrate an ecosystem of others working tools (insurance coming summer 2023). In fall 2023 simplify.art will launch a thefirst AI-curated market place that can suggest artworks based on their context and meaning.

Portfolio highlights

• ShowYou — They are developing the first digital solution dedicated to real estate developers for the management of acquisition modifying works (TMA). They created the first configurator in interactive plans allowing the customer to study his own modifications under the control of the promoter. With SHOW YOU: - save time - clarify and make the work morereliable - improve the satisfaction of your customers
• Reden Solar — Reden Solar develops, finances, builds, and operates solar photovoltaic power plants in Europe and Latin America with an installed portfolio of 762MW and a portfolio under development of 15GW. France and Spain are its main markets, and it has recently expanded its presence in Greece and Italy.
• Gunvor Group — Gunvor Group is one of the world’s largest independent commodities trading houses by turnover, creating logistics solutions that safely and efficiently move physical energy from where it is sourced and stored to where it is demanded most. With strategic investments in industrial infrastructure—refineries, pipelines, storage, terminals, mining andupstream—Gunvor further generates sustainable value across the global supply chain for its customers.

Portfolio highlights

• evidanza — evidanza GmbH is a software provider of business intelligence solutions for reporting, planification, OLAP-analysis, risk management, costs calculations, IFRS- and USGAAP-reporting. The company is headquartered in Salching, Germany.
• SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
• EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.

Portfolio highlights

• Wikitude — Wikitude Augmented Reality empowers your iOS, Android & Smart Glasses apps with Image & Object Tracking, Instant tracking (SLAM), Geo AR, and more.
• 42matters AG — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
• Organica Water — Organica Water is a global provider of innovative solutions for the treatment and recycling of wastewater. Over the past two decades Organica has developed a truly unique approach, enabling customers all over the world to build and operate space and energy efficient biological wastewater treatment plants (WWTPs) that blend harmoniously into urbanand residential population centers, ultimately lowering infrastructure costs and facilitating reuse and recycling of treated wastewater. Established in 1998, Organica began as a traditional wastewater design-build company focused exclusively on the Hungarian market. During the first nine years of its life the company built over 75 municipal, commercial, and industrial WWTPs using a variety of different technologies, while continually investing into R&D to futher develop its own IFAS-type solution for biological wastewater treatment. In 2007 Organica sold it's design-build business to focus exclusively on the commercialization of its own biological wastewater treatment solution on a global basis. Today, Organica is an international company operating on three different continents, and the world leader in Fixed-Bed Biofilm Activated Sludge (FBAS) technology,with more than 25 operating references all over the world, and nearly a dozen additional Organica-powered WWTPs currently under construction.

Portfolio highlights

• Fermify — We are here to domesticate microorganisms and build simple and fully automated production platform to address the issue of large-scale milk protein production
• Jolt Electrodes — Jolt Solutions is an innovative catalytic coatings for industrial electrodes. Learn more about the key benefits of Green Hydrogen.
• Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.

Portfolio highlights

• Loewi — Loewi allows you to sell your two-wheeled companion.
• Revivo — Revivo is an online marketplace for electronics spare parts, tools & accessories.
• Arda Biomaterials — Arda Biomaterials transforms waste feedstocks into smarter, circular biomaterials for fashion, home goods, automotive and more.

Portfolio highlights

• FINDIQ — FINDIQ is a young company based in the heart of the Ostwestfalen-Lippe industrial zone. We have developed a novel strategy as a software producer to intelligently integrate knowledge management and help solutions for machine service. FINDIQ develops its service solution with the industry, whether for machine makers, operators, or service providers.
• Fermify — We are here to domesticate microorganisms and build simple and fully automated production platform to address the issue of large-scale milk protein production
• Recyda GmbH — All-in-one Packaging Recyclability Management

Portfolio highlights

• Replay — Reprogramming biology by writing and delivering big DNA
• Oxford Ionics — Oxford Ionics is delivering world-leading innovations to create the most powerful, accurate and reliable quantum computers.
• Osler Diagnostics — Lab-quality diagnostics for anyone, anywhere, at any time

Portfolio highlights

• Sarcura — Sarcura develops a machine platform for the large scale, GMP manufacturing of personalized cell therapies. Our target is to scale global manufacturing capacity for these life saving, patient specific cancer treatments, cost effective and safe for a all patients. We will transform existing manufacturing paradigms by using semiconductor technologyto bring bioprocess control to cellular level.

Portfolio highlights

• Sarcura — Sarcura develops a machine platform for the large scale, GMP manufacturing of personalized cell therapies. Our target is to scale global manufacturing capacity for these life saving, patient specific cancer treatments, cost effective and safe for a all patients. We will transform existing manufacturing paradigms by using semiconductor technologyto bring bioprocess control to cellular level.

Portfolio highlights

• SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
• EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.

Portfolio highlights

• Arsanis — Arsanis is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. A deep understanding of the pathogenesis of infection, paired with access to some of the most advanced mAb discovery techniques and platforms available today, has positioned Arsanis to build andadvance a pipeline of novel mAbs with multiple mechanisms of action and high potency against their intended targets.The company’s lead clinical program, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in Phase 2 clinical trial for the prevention of S. aureus pneumonia in high-risk, mechanically ventilated patients. In addition to ASN100, its preclinical pipeline is comprised of mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus.Arsanis is a U.S. company headquartered in Waltham, Massachusetts, with European research and preclinical development operations headquartered in Vienna, Austria (Arsanis Biosciences GmbH).
• Topas Therapeutics — Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s naturalimmunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus vulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering.Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies.Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.
• Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.

Portfolio highlights

• Nabriva Therapeutics — Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections.

Portfolio highlights

• Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
• Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
• Ariceum Therapeutics — Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.

Portfolio highlights

• Equinom — Equinom is a fully integrated food-tech company, combining agricultural know-how, culinary expertise and deep technology to develop delicious, nutritious, affordable and sustainable non-GMO plant-based ingredients – from the ground up.Sustainable, plant-based proteins are key to feeding Earth’s 10B people by 2050 The plant-based food market grew27% in 2020 and is projected to reach $162B by 2030.The industry is unable to supply the full demand for food vs. feed For decades, crops have been farmed primarily for animal feed – not for human consumption. To be palatable in human food, these crops require extensive and expensive processing. . With limited processing facilities equipped for this use, the industry is on track to supply only 50% of projected demand for plant-based foods.What is Equinom doing about it? Equinom is using science and technology to develop superior ingredients naturally, at the source – in a fraction of the time typically required to breed new crops. Equinom crops are bred naturally, without genetic editing or modification, and are optimized to make meat and dairy analogues more delicious, nutritious, cost-effective and sustainable. Ingredients designed by deep tech to bring out nature’s best The company’s proprietary Manna™ technology platform uses AI to speed the development of superior, high-yield, non-GMO ingredients as nature intended – featuring the quality traits that satisfy consumer expectations. The technology also ensures biodiversity and climate resilience that are critical to ensure food security in light of climate change. What makes Equinom a compelling foodtech investment and collaborator? Working with great partners including Meatless Farm, Roquette with GoodMills Group., Equinom is recognized as a trusted developer and supplier of unrivaled ingredients. Prestigious strategic investors such as BASF and Roquette have helped position Equinom as one of the breakout Round C companies to fuel the worldwide surge in plant-based eating.
• UPSIDE Foods — Growing real meat directly from animal cells.
• Arkeon Biotechnologies — Arkeon turns CO2 into functional, carbon-negative ingredients for food

Portfolio highlights

• Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.

Portfolio highlights

• V7 — The world's best deep learning teams use V7's tools to create high-performing computer vision models.
• GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
• Sereact — Discover the world's easiest pick-and-pack automation solution. Significant cost savings, productive 24/7, deployment in one day and no training required.

Portfolio highlights

• Farmless — A farmless fermentation platform has the potential to create an entirely new food repertoire, producing proteins, carbohydrates, beneficial fats, vitamins, and minerals from the ground up," explained Oner. "We are creating a new interface between food and electricity by domesticating microbes chosen for their food properties and abilityto grow on renewable energy-based feedstocks.
• Black Sheep Foods — Black Sheep Foods seeks to be the world leader in plant-based lamb and other wild and heritage meats.
• Arkeon Biotechnologies — Arkeon turns CO2 into functional, carbon-negative ingredients for food

Portfolio highlights

• Lavie bio — Improve food quality, agricultural sustainability and productivity through the introduction of microbiome based ag-biological products.
• Arkeon Biotechnologies — Arkeon turns CO2 into functional, carbon-negative ingredients for food

Portfolio highlights

• PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
• twig bio — twig bio operates as a bioengineering startup. twig bio using AI and robotics to find sustainable replacements for harmful ingredients.
• WNWN Food Labs — We're WNWN Food Labs and we love food. We're creating delicious, sustainable and ethical alternatives to unsustainable and ethically dubious foods. We're starting with cacao-free chocolate. Changing chocolate? It's Win-Win #alt-chocolate #altchocolate #alt-universe #altuniverse #alt-protein

Portfolio highlights

• Aigen — Aigen provides a robotics service platform to improve soil health. With a focus on providing better data and direct action for farmers.
• BurnBot — Burnbot is a tech forward provider of wildfire mitigation, vegetation management, and prescribed fire operations. We offer force-multiplying solutions that reduce the risk of wildfire damage for critical infrastructure, firefighting agencies, agriculture, private enterprise, public lands, conservati
• Arkeon Biotechnologies — Arkeon turns CO2 into functional, carbon-negative ingredients for food

Portfolio highlights

• Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
• ZiO Health — ZiO Health develops multi-functional electronic devices for measuring, testing and detecting the molecular composition of chemical and biological substances for the presence, absence, or quantity of target molecules.
• Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.